J Mirro
- Hematology top 1%
- Acute Myeloid Leukemia Research 19
- Chronic Myeloid Leukemia Treatments 6
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
-
- Acute Lymphoblastic Leukemia research 14
-
- Lymphoma Diagnosis and Treatment 3
- Oncology top 10%
- Neutropenia and Cancer Infections 2
- CAR-T cell therapy research 1
-
- Retinoids in leukemia and cellular processes 1
J Mirro
21 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 63
- Hematology 882
- Genetics 325
- Public Health, Environmental and Occupational Health 695
- Pathology and Forensic Medicine 249
- Oncology 242
Countries citing papers authored by J Mirro
This map shows the geographic impact of J Mirro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mirro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mirro more than expected).
Fields of papers citing papers by J Mirro
This network shows the impact of papers produced by J Mirro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mirro. The network helps show where J Mirro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Mirro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia. | 1994 | 36 |
| 2 | 1992 | 120 | |
| 3 | Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. | 1992 | 34 |
| 4 | 1991 | 84 | |
| 5 | 1990 | 86 | |
| 6 | 1990 | 4 | |
| 7 | 1990 | 102 | |
| 8 | 1990 | 78 | |
| 9 | 1989 | 18 | |
| 10 | 1988 | 41 | |
| 11 | 1988 | 132 | |
| 12 | 1987 | 39 | |
| 13 | 1986 | 25 | |
| 14 | 1986 | 199 | |
| 15 | 1986 | 24 | |
| 16 | Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia. | 1986 | 8 |
| 17 | Transient myeloproliferative syndrome in a phenotypically normal infant. | 1985 | 27 |
| 18 | Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon. | 1985 | 10 |
| 19 | 1985 | 44 | |
| 20 | 1984 | 174 |
About J Mirro
J Mirro is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (14 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Lymphoma Diagnosis and Treatment (3 papers), Neutropenia and Cancer Infections (2 papers), Retinoids in leukemia and cellular processes (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Hematology (882 citations), Genetics (325 citations) and Public Health, Environmental and Occupational Health (695 citations). J Mirro has collaborated with scholars based in United States and Germany. Frequent co-authors include MJ Schell, Susan L. Melvin, Ching‐Hon Pui, Raymond L. Blakley, Victor M. Santana, David K. Kalwinsky, C-H Pui, SB Murphy, S Stass and SB Murphy. Their work appears in journals such as Blood, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.